ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HEPA Hepion Pharmaceuticals Inc

1.37
0.08 (6.20%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Hepion Pharmaceuticals Inc HEPA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.08 6.20% 1.37 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.29 1.27 1.44 1.37 1.29
more quote information »

Recent News

Date Time Source Heading
4/19/202415:30GLOBEHepion Pharmaceuticals Initiates Wind-Down Activities in..
2/16/202408:02EDGAR2Form 8-K - Current report
2/16/202407:00GLOBEHepion Pharmaceuticals Announces Exercise of Warrants for..
2/14/202414:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/03/202416:15GLOBEHepion Pharmaceuticals to Present at NASH-TAG 2024
1/03/202415:30EDGAR2Form 8-K - Current report
12/07/202307:00GLOBEHepion Pharmaceuticals Announces Restructuring Plan to..
11/28/202315:15GLOBEHepion Pharmaceuticals to Present at the 7th Obesity & NASH..
11/13/202315:05GLOBEHepion Pharmaceuticals Announces Major Reductions in Liver..
11/10/202307:50GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
11/08/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/25/202307:30GLOBEHepion Pharmaceuticals’ Rencofilstat Demonstrates..
9/29/202307:00GLOBEHepion Pharmaceuticals Announces $5.0 Million Registered..
9/21/202315:05GLOBEHepion Pharmaceuticals to Participate in 2023 Cantor Global..
9/21/202307:00GLOBENew Anti-Cancer Opportunities Revealed for Hepion..
9/19/202308:00GLOBEHepion Pharmaceuticals Discovers Novel Rencofilstat Action..
9/18/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202307:45GLOBERencofilstat Produces Positive Outcomes in Translational..
9/06/202315:40EDGAR2Form 8-K - Current report
9/06/202315:30GLOBEHepion Pharmaceuticals Announces Management Changes
7/24/202315:04EDGAR2Form 8-K - Current report
7/21/202315:41EDGAR2Form 8-K - Current report
7/21/202315:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/15/202315:45GLOBEHepion Pharmaceuticals to Present Two Posters at EASL..
6/15/202307:22GLOBEHepion Pharmaceuticals Announces Passing of Key Safety..
5/24/202315:45GLOBEHepion Pharmaceuticals to Highlight AI-POWR™ at the 2023..
5/22/202306:00GLOBEHepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial..
5/19/202315:05GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
5/10/202310:15GLOBEHepion Pharmaceuticals, Inc. Announces Reverse Stock Split

Your Recent History

Delayed Upgrade Clock